In the present study, we demonstrate that resistance towards topoisomerase inhibitors in SCLC proceeds through a sGC/PKG axis but without reduction in apoptosis in vivo (measured at single time-point at study conclusion). The gene discussed is PRKG1; the disease is small cell lung carcinoma.